Martin Pfister
Direttore/Membro del Consiglio presso WMT AG
Profilo
Dr. Martin Pfister studied medicine and pharmacy at the University of Greifswald and New York University and received his doctorate in immunology.
He worked in various academic laboratories.
Since 2000 he has been active in the start-up scene.
He took over management positions and is co-founder of two successful companies in the fields of diagnostics & health services.
In 2010 he transferred to the HTGF on the investor side.
With his long-standing experience in drug development/gene therapy and medical technology/diagnostics, he is a valued sparring partner for portfolio companies in the fields of biotechnology and healthcare.
He also holds several advisory board positions with portfolio companies.
Posizioni attive di Martin Pfister
| Società | Posizione | Inizio |
|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investitore di Private Equity | 12/05/2011 |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | - |
WMT AG
 WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Martin Pfister
| Società | Posizione | Fine |
|---|---|---|
| Data Information Intelligence GmbH | Fondatore | 31/10/2018 |
Formazione di Martin Pfister
| Universität Leipzig | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |
WMT AG
WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Commercial Services |
| Data Information Intelligence GmbH | |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
- Borsa valori
- Insiders
- Martin Pfister
